Format
Sort by
Items per page

Send to

Choose Destination

Best matches for prostate cancer curcumin:

Search results

Items: 1 to 20 of 334

1.

Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastastatic spreading in prostate cancer cells.

Bessone F, Argenziano M, Grillo G, Ferrara B, Pizzimenti S, Barrera G, Cravotto G, Guiot C, Stura I, Cavalli R, Dianzani C.

Nanotechnology. 2019 Jan 17. doi: 10.1088/1361-6528/aaff96. [Epub ahead of print]

PMID:
30654342
2.

Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells.

Belluti S, Orteca G, Semeghini V, Rigillo G, Parenti F, Ferrari E, Imbriano C.

Int J Mol Sci. 2018 Dec 21;20(1). pii: E28. doi: 10.3390/ijms20010028.

3.

A Self-degradable Curcumin Polymer with Anti-cancer Activity.

O'Connor NA, Einbond LS, Redenti S, Sauane M, Jitianu A.

J Appl Polym Sci. 2018 Dec 15;135(47). pii: 46867. doi: 10.1002/app.46867. Epub 2018 Aug 27.

PMID:
30555179
4.

Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo.

Mapoung S, Suzuki S, Fuji S, Naiki-Ito A, Kato H, Yodkeeree S, Ovatlarnporn C, Takahashi S, Limtrakul Dejkriengkraikul P.

Cancer Sci. 2018 Nov 30. doi: 10.1111/cas.13897. [Epub ahead of print]

5.

Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy.

Saadipoor A, Razzaghdoust A, Simforoosh N, Mahdavi A, Bakhshandeh M, Moghadam M, Abdollahi H, Mofid B.

Phytother Res. 2018 Nov 14. doi: 10.1002/ptr.6230. [Epub ahead of print]

PMID:
30427093
6.

3D-QSAR and Molecular Docking Studies on Design Anti-prostate Cancer Curcumin Analogues.

Meng X, Cui L, Song F, Luan M, Ji J, Si H, Duan Y, Zhai H.

Curr Comput Aided Drug Des. 2018 Oct 29. doi: 10.2174/1573409914666181029123746. [Epub ahead of print]

PMID:
30370853
7.

Molecular Responses of Cancers by Natural Products: Modifications of Autophagy Revealed by Literature Analysis.

Yeung AWK, El-Demerdash A, Berindan-Neagoe I, Atanasov AG, Ho YS.

Crit Rev Oncog. 2018;23(5-6):347-370. doi: 10.1615/CritRevOncog.2018027566.

PMID:
30311565
8.

Metallo-Curcumin-Conjugated DNA Complexes Induces Preferential Prostate Cancer Cells Cytotoxicity and Pause Growth of Bacterial Cells.

Vellampatti S, Chandrasekaran G, Mitta SB, Lakshmanan VK, Park SH.

Sci Rep. 2018 Oct 8;8(1):14929. doi: 10.1038/s41598-018-33369-z.

9.

Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer.

Khurana N, Sikka SC.

Cancers (Basel). 2018 Sep 25;10(10). pii: E352. doi: 10.3390/cancers10100352. Review.

10.

Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.

Patanapongpibul M, Zhang C, Chen G, Guo S, Zhang Q, Zheng S, Wang G, Chen QH.

Bioorg Med Chem. 2018 Sep 1;26(16):4751-4760. doi: 10.1016/j.bmc.2018.08.018. Epub 2018 Aug 13.

PMID:
30121214
11.

Isolation and Structural Characterization of Bioactive Molecules on Prostate Cancer from Mayan Traditional Medicinal Plants.

Fort RS, Trinidad Barnech JM, Dourron J, Colazzo M, Aguirre-Crespo FJ, Duhagon MA, Álvarez G.

Pharmaceuticals (Basel). 2018 Aug 14;11(3). pii: E78. doi: 10.3390/ph11030078.

12.

Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties.

Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Ramezani M, Sahebkar A.

J Cell Physiol. 2018 Dec;233(12):9247-9260. doi: 10.1002/jcp.27029. Epub 2018 Aug 4. Review.

PMID:
30076727
13.

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc) in patients with locally advanced or metastatic cancer.

Greil R, Greil-Ressler S, Weiss L, Schönlieb C, Magnes T, Radl B, Bolger GT, Vcelar B, Sordillo PP.

Cancer Chemother Pharmacol. 2018 Oct;82(4):695-706. doi: 10.1007/s00280-018-3654-0. Epub 2018 Aug 3.

14.

Polyacetal-Based Combination Therapy for the Treatment of Prostate Cancer.

Plyduang T, Armiñán A, Movellan J, England RM, Wiwattanapatapee R, Vicent MJ.

Macromol Rapid Commun. 2018 Oct;39(19):e1800265. doi: 10.1002/marc.201800265. Epub 2018 Jul 30.

PMID:
30062740
15.

Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.

Coker-Gurkan A, Celik M, Ugur M, Arisan ED, Obakan-Yerlikaya P, Durdu ZB, Palavan-Unsal N.

Amino Acids. 2018 May 16. doi: 10.1007/s00726-018-2581-z. [Epub ahead of print]

PMID:
29770869
16.

Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development.

Safe S, Abbruzzese J, Abdelrahim M, Hedrick E.

Cancer Prev Res (Phila). 2018 Jul;11(7):371-382. doi: 10.1158/1940-6207.CAPR-17-0407. Epub 2018 Mar 15. Review.

PMID:
29545399
17.

Curcumin suppressed the prostate cancer by inhibiting JNK pathways via epigenetic regulation.

Zhao W, Zhou X, Qi G, Guo Y.

J Biochem Mol Toxicol. 2018 May;32(5):e22049. doi: 10.1002/jbt.22049. Epub 2018 Feb 27.

PMID:
29485738
18.

Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials.

Gdowski A, Johnson K, Shah S, Gryczynski I, Vishwanatha J, Ranjan A.

J Nanobiotechnology. 2018 Feb 12;16(1):12. doi: 10.1186/s12951-018-0339-0.

19.

Maspin Enhances the Anticancer Activity of Curcumin in Hormone-refractory Prostate Cancer Cells.

Cheng WL, Huang CY, Tai CJ, Chang YJ, Hung CS.

Anticancer Res. 2018 Feb;38(2):863-870.

PMID:
29374713
20.

Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer.

Ide H, Lu Y, Noguchi T, Muto S, Okada H, Kawato S, Horie S.

Cancer Sci. 2018 Apr;109(4):1230-1238. doi: 10.1111/cas.13517. Epub 2018 Feb 19.

Supplemental Content

Loading ...
Support Center